UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase

Science (American Association for the Advancement of Science), 1991-09, Vol.253 (5027), p.1557-1559

1991

Volltextzugriff (PDF)

HIV-1 sensitivity to zidovudine and clinical outcome in children

The Lancet (British edition), 1992-01, Vol.339 (8784), p.15-19

1992

Volltextzugriff (PDF)

Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus

The Pediatric infectious disease journal, 1997-02, Vol.16 (2), p.200-204

1997

Volltextzugriff (PDF)

Substitution of a commercially available, RNA extraction procedure in an HIV-1 genotyping system improves sensitivity and allows reduced sample volume

Journal of virological methods, 2001-07, Vol.96 (1), p.1-4

2001

Volltextzugriff (PDF)

Virologic Response of Nine Therapy-Experienced Children Receiving 64 Weeks of Nelfinavir Salvage Therapy

Annals of the New York Academy of Sciences, 2000-11, Vol.918 (1), p.381-385

2000

Volltextzugriff (PDF)

Epidemiology of dolutegravir (DTG) resistance in ~700 raltegravir-resistant isolates

Antiviral therapy, 2013-01, Vol.18, p.A108-A108

2013

Volltextzugriff (PDF)

Integrase genotypic and phenotypic predictors of antiviral response to dolutegravir (DTG) in subjects with resistance to integrase inhibitors (INIs)

Antiviral therapy, 2013-01, Vol.18, p.A37-A37

2013

Volltextzugriff (PDF)

Evolution of integrase in virus at protocol-defined virological failure from the VIKING-3 study

Antiviral therapy, 2013-01, Vol.18, p.A104-A104

2013

Volltextzugriff (PDF)

HIV-1 sensitivity to zidovudine and clinical outcome

The Lancet (British edition), 1992-03, Vol.339 (8793), p.626-627

1992

Volltextzugriff (PDF)

Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study Group

Journal of acquired immune deficiency syndromes (1988), 1993-08, Vol.6 (8), p.891-897

1993

Volltextzugriff (PDF)

Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study

Journal of acquired immune deficiency syndromes (1988), 1993, Vol.6 (8), p.891-897

1993

Volltextzugriff (PDF)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Volltextzugriff (PDF)

Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance

Viruses, 2023-08, Vol.15 (9), p.1811

2023

Volltextzugriff (PDF)

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatment

AIDS (London), 2009-07, Vol.23 (12), p.1547-1556

2009

Volltextzugriff (PDF)

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study

Journal of acquired immune deficiency syndromes (1999), 2010-09, Vol.55 (1), p.49-57

2010

Volltextzugriff (PDF)

Single wall carbon nanotube fibers extruded from super-acid suspensions: Preferred orientation, electrical, and thermal transport

Journal of applied physics, 2004-01, Vol.95 (2), p.649-655

2004

Volltextzugriff (PDF)

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

The lancet HIV, 2022-05, Vol.9 (5), p.e332-e340

2022

Volltextzugriff (PDF)

Thermoelectric power of p-doped single-wall carbon nanotubes and the role of phonon drag

Physical review letters, 2003-02, Vol.90 (6), p.065503-065503, Article 065503

2003

Volltextzugriff (PDF)

Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors

The Pediatric infectious disease journal, 2004-01, Vol.23 (1), p.15-22

2004

Volltextzugriff (PDF)

Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients

The Pediatric infectious disease journal, 1998-01, Vol.17 (1), p.18-23

1998

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks

HIV clinical trials, 2009-03, Vol.10 (2), p.76-87

2009

Volltextzugriff (PDF)

Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes

AIDS research and human retroviruses, 1999-09, Vol.15 (14), p.1287-1292

1999

Volltextzugriff (PDF)

Efficacité de l’association fixe dolutégravir/abacavir/lamivudine (DTG/ABC/3TC) comparée à atazanavir/ritonavir (ATV/r) et fumarate de ténofovir disoproxil/emtricitabine (TDF/FTC) chez des femmes infectées par le VIH-1 naïves de traitement (ARIA) : analyses des sous-groupes

Médecine et maladies infectieuses, 2017-06, Vol.47 (4), p.S140-S140

2017

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(23)

Sprache

Englisch
(22)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase

HIV-1 sensitivity to zidovudine and clinical outcome in children

Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus

Substitution of a commercially available, RNA extraction procedure in an HIV-1 genotyping system improves sensitivity and allows reduced sample volume

Virologic Response of Nine Therapy-Experienced Children Receiving 64 Weeks of Nelfinavir Salvage Therapy

Epidemiology of dolutegravir (DTG) resistance in ~700 raltegravir-resistant isolates

Integrase genotypic and phenotypic predictors of antiviral response to dolutegravir (DTG) in subjects with resistance to integrase inhibitors (INIs)

Evolution of integrase in virus at protocol-defined virological failure from the VIKING-3 study

HIV-1 sensitivity to zidovudine and clinical outcome

Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study Group

Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatment

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study

Single wall carbon nanotube fibers extruded from super-acid suspensions: Preferred orientation, electrical, and thermal transport

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

Thermoelectric power of p-doped single-wall carbon nanotubes and the role of phonon drag

Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors

Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients

Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks

Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes

Efficacité de l’association fixe dolutégravir/abacavir/lamivudine (DTG/ABC/3TC) comparée à atazanavir/ritonavir (ATV/r) et fumarate de ténofovir disoproxil/emtricitabine (TDF/FTC) chez des femmes infectées par le VIH-1 naïves de traitement (ARIA) : analyses des sous-groupes

Suchergebnisse filtern